Theoretically, RAC could have amazingly bad luck and only...

  1. 523 Posts.
    lightbulb Created with Sketch. 259
    Theoretically, RAC could have amazingly bad luck and only recruit patients with the cancer cell lines that show no improvement in combo with dox.

    The insurance against this is proof of concept of CP would progress the trial forward long enough to push past any statistical outliers.

    That is definitely glass half empty pragmatism. Knowing these preclinical results have over 4/5ths of tested cell lines having positive synergy in combo with dox is glass mostly full optimism.

    I anticipate early read outs with proof/failure of concept before years end (CY).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.29
Change
-0.050(3.75%)
Mkt cap ! $223.2M
Open High Low Value Volume
$1.31 $1.33 $1.28 $125.2K 96.35K

Buyers (Bids)

No. Vol. Price($)
3 21173 $1.28
 

Sellers (Offers)

Price($) Vol. No.
$1.30 6431 2
View Market Depth
Last trade - 15.34pm 23/06/2025 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.